Long-term growth outcomes in children treated for ch

Maureen M. Jonas, Kathleen B. Schwarz, Regino Gonzalez-Peralta, Steven Lobritto, Jean P. Molleston, Karen F. Murray, Philip Rosenthal, Jessica Wen, Cynthia Wat, Vedran Pavlovic, Charles Warne

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.

Original languageEnglish (US)
Pages (from-to)1252-1254
Number of pages3
JournalJournal of Pediatrics
Volume165
Issue number6
DOIs
StatePublished - Dec 1 2014

Keywords

  • HAZ Height-for-age z score LTFU Long-term follow-up PEG-IFN Peginterferon RBV Ribavirin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Fingerprint Dive into the research topics of 'Long-term growth outcomes in children treated for ch'. Together they form a unique fingerprint.

  • Cite this

    Jonas, M. M., Schwarz, K. B., Gonzalez-Peralta, R., Lobritto, S., Molleston, J. P., Murray, K. F., Rosenthal, P., Wen, J., Wat, C., Pavlovic, V., & Warne, C. (2014). Long-term growth outcomes in children treated for ch. Journal of Pediatrics, 165(6), 1252-1254. https://doi.org/10.1016/j.jpeds.2014.08.010